肿瘤转移的预警和预防研究所
(Cancer Metastasis Alert and Prevention Center）
福州大学肿瘤转移的预警和预防研究所（CMAPC）聚集了药学学科的优秀人才，建立了生物化学研究室、分子细胞学研究室、肿瘤药理学研究室、细胞培养-分选工作站、药化合成室、植物和海洋药物研究室、生物纳米制剂室、药物分析、药代动力学、生物分析化学室，涵盖了药学领域的全部分支，构成了我校省级药学重点学科的核心，开辟了多门与现代生物医药研发相关的课程，毕业研究生100%在985、省级重点高校、科研单位、药企就职。CMAPC拥有国家特聘教授、闽江学者、省杰青/省特支人才、省教育厅1000学科带头人。CMAPC在药理学、药剂学、药物分析、分析化学、生物化工和食品安全与药物合成领域招收研究生和博士后。目前已有博士后、博/硕士研究生60人，研究生多次夺得国内外研究奖学金，年发表SCI论文约30篇（多为一区和药学顶级期刊），累积年IF170，表明我们在药学领域处于全球领先地位。我们与美国药学会（AAPS）、国内外许多药学院建立了长期的学术交流与访学关系。
我们是福建省肿瘤转移药物干预重点实验室的核心。研究重点是，与临床结合，在微观分子细胞学水平和宏观整体水平上，研究原发性肿瘤在手术后再转移的机制及其控制方法；在综合性地认知肿瘤转移的动力学、内、外影响因素的基础上，研发能可靠预警肿瘤手术后再转移的方法、技术和产品，以填补这一全球人口健康领域的重大空白。2016年我们在肿瘤转移药物预防领域发表论文占全球总量35.7%，可见我们在此领域的重要影响！
The Cancer Metastasis Alert and Prevention Center (CMAPC) of Fuzhou University recruited excellent pharmaceutical talents, and is composed of biochemical laboratory, molecular and cellular laboratory, cancer pharmacological laboratory, cell culture and sorting laboratory, chemical synthesis laboratory, plant and ocean pharmaceutical laboratory, bionanotechnology pharmaceutical laboratory, pharmaceutical analysis laboratory, pharmacokinetics laboratory, and bioanalysis chemistry laboratory. The research interests of CMAPC cover many fields of pharmaceutics and it becomes the core of the key disciplines of Fuzhou University within Fujian Province. At CMAPC, there are one Distinguished Professor of “The China Recruitment Program of Global Experts”, one Min-jiang Scholar Professor, one Full Professor, and three Associate Professors and alike. CMAPC offers many courses related to research and development of modern biomedicines. It recruits Graduates and Postdoctors from areas of pharmacology, pharmaceutics, pharmaceutical analysis, analytical chemistry, biochemical engineering, and food safety and medicinal chemistry. There are about 30 more of postdoctors, PhD and Master Graduates at CMAPC.
The research interest focuses on 1) studying the mechanisms of cancer metastasis after surgery from cellular and molecular basis as well as from mammal body as a whole; 2) discovering key pathways that control cancer metastasis; 3) establishing animal models that can reliably mimic metastasis in patients. After comprehensive understanding of metastasis dynamics, internal and external elements that deactivate or reactivate circulating tumor cells, we will develop various methods, techniques and products that can reliably alert metastasis for cancer survivors; develop various techniques and products (including drug combination, nanomaterials, biopharmaceuticals, traditional Chinese medicines, and others) that can efficiently and safely prevent cancer survivors from potential metastasis. Since it was founded in 2012, CMAPC has published more than 30 papers and its faculty has been invited for more than 10 presentations at international and domestic scientific conferences. CMAPC has established academic ties with the American Association of Pharmaceutical Scientists (AAPS) as well as Colleges of Pharmaceutics abroad and at home. Its graduates have received many scientific conference Awards due to the high quality of their research presentations.
